| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0574-1405-28 | 0574-1405 | HUMAN PRESCRIPTION DRUG | LENALIDOMIDE | lenalidomide | CAPSULE | ORAL | 20260131 | N/A | ANDA | ANDA217265 | Padagis US LLC | LENALIDOMIDE | 5 mg/1 | 28 CAPSULE in 1 BOTTLE (0574-1405-28) |
| 0574-1410-28 | 0574-1410 | HUMAN PRESCRIPTION DRUG | LENALIDOMIDE | lenalidomide | CAPSULE | ORAL | 20260131 | N/A | ANDA | ANDA217265 | Padagis US LLC | LENALIDOMIDE | 10 mg/1 | 28 CAPSULE in 1 BOTTLE (0574-1410-28) |
| 0574-1415-21 | 0574-1415 | HUMAN PRESCRIPTION DRUG | LENALIDOMIDE | lenalidomide | CAPSULE | ORAL | 20260131 | N/A | ANDA | ANDA217265 | Padagis US LLC | LENALIDOMIDE | 15 mg/1 | 21 CAPSULE in 1 BOTTLE (0574-1415-21) |
| 0574-1420-21 | 0574-1420 | HUMAN PRESCRIPTION DRUG | LENALIDOMIDE | lenalidomide | CAPSULE | ORAL | 20260131 | N/A | ANDA | ANDA217265 | Padagis US LLC | LENALIDOMIDE | 20 mg/1 | 21 CAPSULE in 1 BOTTLE (0574-1420-21) |
| 0574-1425-21 | 0574-1425 | HUMAN PRESCRIPTION DRUG | LENALIDOMIDE | lenalidomide | CAPSULE | ORAL | 20260131 | N/A | ANDA | ANDA217265 | Padagis US LLC | LENALIDOMIDE | 25 mg/1 | 21 CAPSULE in 1 BOTTLE (0574-1425-21) |
| 0574-1402-28 | 0574-1402 | HUMAN PRESCRIPTION DRUG | LENALIDOMIDE | lenalidomide | CAPSULE | ORAL | 20260131 | N/A | ANDA | ANDA217265 | Padagis US LLC | LENALIDOMIDE | 2.5 mg/1 | 28 CAPSULE in 1 BOTTLE (0574-1402-28) |